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Summary
The major facilitator superfamily transporter Rv1410 
and the lipoprotein LprG (Rv1411) are encoded by a 
conserved two-gene operon and contribute to viru-
lence in Mycobacterium tuberculosis. Rv1410 was 
originally postulated to function as a drug efflux 
pump, but recent studies suggested that Rv1410 and 
LprG work in concert to insert triacylglycerides and 
lipoarabinomannans into the outer membrane. Here, 
we conducted microscopic analyses of 
Mycobacterium smegmatis lacking the operon and 
observed a cell separation defect, while surface 
rigidity measured by atomic force microscopy was 
found to be increased. Whereas Rv1410 expressed in 
Lactococcus lactis did not confer drug resistance, 
deletion of the operon in Mycobacterium abscessus 
and M. smegmatis resulted in increased susceptibil-
ity toward vancomycin, novobiocin and rifampicin. A 
homology model of Rv1410 revealed a periplasmic 
loop as well as a highly conserved aspartate, which 
were found to be essential for the operon’s function. 
Interestingly, influx of the fluorescent dyes 
BCECF-AM and calcein-AM in de-energized M. 
smegmatis cells was faster in the deletion mutant. 
Our results unambiguously show that elevated drug 
susceptibility in the deletion mutant is caused by 
increased drug influx through a defective mycobac-
terial cell envelope and not by drug efflux mediated 
by Rv1410.
Introduction
The pathogenic bacterium Mycobacterium tuberculo-
sis is responsible for approximately 1.7 million cases of 
death every year. In particular, the emergence of multi-
drug (MDR) and extensively drug-resistant strains are a 
global health threat. Mycobacteria are intrinsically resis-
tant against many antibiotics due to their thick and com-
plex outer membrane (Hoffmann et al., 2008). The main 
constituents of the mycobacterial cell wall are mycolic 
acids covalently connected to the arabinogalactan layer, 
and a plethora of glycolipids such as trehalose dimyco-
lates (TDMs) and lipoarabinomannans (LAMs) that inter-
act non-covalently with the mycolic acids (Dhiman et al., 
2011). Due to its biological uniqueness, many TB-specific 
drugs are targeting the assembly of this cell envelope and 
the biosynthesis of its lipids. The composition and biosyn-
thesis of this formidable cell barrier are well established. 
In contrast, much less is known about how these lipids 
are integrated into the cell wall or how the precursors are 
transported across the cytoplasmic membrane.
The major facilitator superfamily (MFS) transporter 
Rv1410 (also called P55) is located in the cytoplasmic 
membrane. Initial studies in Mycobacterium bovis have 
established that Rv1410 shares homology to multidrug 
efflux proteins and is encoded in a highly conserved 
two-gene operon together with the lipoprotein LprG (also 
named Rv1411 or P27) (Bigi et al., 2000). Overexpression 
of rv1410 in Mycobacterium smegmatis conferred ami-
noglycoside and tetracycline resistance, which could be 
reversed in the presence of the protonophore carbonyl 
cyanide m-chlorophenylhydrazone (CCCP), as well as 
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the efflux pump inhibitors verapamil and reserpine, sug-
gesting that it functions as a proton-driven drug efflux 
pump (Silva et al., 2001). M. bovis Δrv1410 exhibited 
higher susceptibility toward a number of drugs including 
rifampicin and clofazimine (Ramon-Garcia et al., 2009), 
and deletion of the homologous operon in M. smegma-
tis resulted in increased susceptibility toward ethidium 
(Farrow and Rubin, 2008). Interestingly, the authors of 
these studies noted altered colony morphology, growth 
attenuation, cell clumping and hampered sliding motility, 
suggesting that lack of this operon leads to altered cell 
surface properties. Furthermore, it was found that LprG is 
needed for the normal functioning of Rv1410, suggesting 
that they operate in concert (Farrow and Rubin, 2008). 
Structural and functional analyses of the lipoprotein LprG 
permitted insights from a completely different angle. LprG 
was found to associate with the triacylated Toll-like recep-
tor 2 (TLR2) agonists LAM, lipomannan and phosphatidy-
linositol mannoside (PIM). This notion was corroborated 
by a structure of LprG co-crystallized in complex with the 
LAM precursor Ac1PIM2, revealing a hydrophobic pocket 
accommodating the three alkyl chains of the lipid (Drage 
et al., 2010). Surface plasmon resonance (SPR) studies 
using purified LprG and triacylated lipids including LAM 
further confirmed this molecular interaction and revealed 
a secondary sugar-binding site outside of the hydropho-
bic pocket, resulting in a particularly high affinity of LprG 
for LAMs (Shukla et al., 2014). Very recent studies in 
addition revealed molecular interactions of purified LprG 
with TLR2 (Shukla et al., 2018). Virulence of M. tubercu-
losis ΔlprG in BALB/c mice was clearly attenuated and 
the mutant exhibits impaired macrophage entry and fails 
to inhibit phagosome–lysosome fusion (Bigi et al., 2004). 
Attenuated virulence was initially proposed to be caused 
by decreased surface localization of LAMs, implying 
that LprG transports LAMs from the plasma membrane 
into the cell envelope (Gaur et al., 2014; Shukla et al., 
2014). However, a recent study refuted this hypothesis by 
showing that the deletion mutant also multiplies slower in 
mice lacking key elements of either the innate or adap-
tive immune system, which are thought to be triggered by 
LAMs (Martinot et al., 2016). Lipidome analyses revealed 
that deletion of the lprG-rv1410 operon leads to intracel-
lular accumulation of triacylglycerides (TAGs) and that 
overexpression of the locus in turn increases the levels of 
TAGs in the culture medium (Martinot et al., 2016). This 
pointed at a metabolic defect in the deletion mutant being 
responsible for decreased virulence in mice and further 
lent support to the operon’s role in the transport of tri-
acylated lipids. In a very recent study, LprG was found 
to interact with various periplasmic proteins, including 
mycolyltransferase Ag85A, which catalyzes the formation 
of TDM in the cell wall (Touchette et al., 2017).
The available data about the lprG-rv1410 operon of 
M. tuberculosis and the homologous operons of other 
mycobacterial species (henceforth called collectively 
lprG-mfs operons) so far mainly addressed the function 
of the lipoprotein LprG, namely its possible role in the 
transport of LAMs and TAGs from the plasma membrane 
into the outer membrane and the immunological conse-
quences of a reduced LAM exposure at the surface of 
the mycobacterial cell. By contrast, comparatively little is 
known about the function of the proton-driven transporter 
Rv1410, in particular with regard to its suggested dual 
role of being a drug efflux pump as well as a lipid trans-
porter. To shed light on the function of Rv1410, we cloned, 
expressed and purified Rv1410 and studied its interac-
tion with the lipoprotein LprG in vitro. Deletion mutants 
of the lprG-mfs operon were constructed in M. smegma-
tis and in Mycobacterium abscessus and evaluated for 
drug susceptibility and transport of fluorescent dyes to 
resolve Rv1410’s role as drug efflux pump. A homology 
model of Rv1410 was generated, which formed the basis 
to functionally characterize a conserved aspartate and a 
periplasmic loop. Finally, cell surface properties and mor-
phology of the M. smegmatis deletion mutant were stud-
ied using AFM and microscopy techniques offering insight 
into the biophysical role of the Rv1410 operon.
Results
Homology model of Rv1410
According to the transporter classification database 
(http://www.tcdb.org), Rv1410 belongs to the MFS sub-
class drug:H+ antiporter-2 (DHA2), which mainly con-
sists of drug efflux pumps. DHA2 members all feature 
14 transmembrane helices (TMs), namely two bundles of 
six TMs, which are common to all MFS transporters, and 
an additional helix pair placed between these bundles 
(6+2+6 TMs) (Reddy et al., 2012). Other well character-
ized DHA2 family members are the drug efflux pumps LfrA 
from M. smegmatis (Sander et al., 2000) and QacA from 
Staphylococcus aureus (Paulsen et al., 1996a). Currently, 
there is no structure available for a DHA2 transporter. 
The closest structural homologue of Rv1410 is PepTSo2 of 
Shewanella oneidensis (sequence identity of 14.2% and 
coverage of 0.844 according to the SwissModel server), 
an MFS transporter belonging to the subfamily of pro-
ton-dependent oligopeptide transporters, which share 
the 6+2+6 helical arrangement with Rv1410 (Guettou et 
al., 2013; Newstead, 2015). Therefore, a homology model 
was generated based on the coordinates of PepTSo2 
(PDB ID: 4LEP) using the SwissModel server (Biasini et 
al., 2014) (Fig. 1A). The model contains the classical fold 
common to all MFS transporters comprising TM1–12 and 
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the two additional helices (called HA and HB) connecting 
the two lobes of the transporter, whose functional role is 
currently unclear (Newstead, 2015). Interestingly, Rv1410 
contains a periplasmic loop consisting of 34 amino acids 
placed between TM11 and TM12 (Fig. 1A), which is not 
present in any of the known MFS structures and whose 
function is unknown.
A sequence alignment involving Rv1410, the L. lactis 
drug efflux pump LmrP and the Escherichia coli drug 
efflux pump MdfA – both belonging to the DHA1 family of 
MFS transporters containing 12 TMs – along with PepTSo2 
and LfrA revealed a highly conserved aspartate (D70 in 
Rv1410) (Fig. 1B). This aspartate is part of the conserved 
motif A (consensus sequence GrLaDrfGrRRv) located at 
the cytoplasmic loop between TM2 and TM3 in all MFS 
transporters (Fig. 1A) (Paulsen et al., 1996b). Mutation of 
this aspartate into cysteine in LmrP or alanine in MdfA, 
respectively, was shown to completely abrogate drug 
efflux in these transporters (Mazurkiewicz et al., 2004; 
Sigal et al., 2006). A double electron–electron resonance 
Fig. 1. Homology model of Rv1410 and conservation of the lprG-mfs operon.  
A. Homology model of Rv1410 based on the coordinates of PepTSo2 (PDB ID: 4LEP). A highly conserved aspartate (D70) and a unique 
periplasmic loop between TM11 and TM12 are labeled.  
B. Sequence alignment of MFS transporters showing the conserved motif A between TM2 and TM3. An aspartate residue (highlighted in red) 
is strictly conserved, and was mutated to asparagine to inactivate the transporters (DtoN mutation).  
C. Conservation of LprG and the MFS transporter among different mycobacterial species. MAB, M. abscessus; MSMEG, M. smegmatis; Rv, 
M. tuberculosis; MMAR, M. marinum. The numbers correspond to amino acid sequence identities.  
D. M. smegmatis dKO was complemented with lprG-mfs operons from M. smegmatis (MSMEG_3069-70), M. tuberculosis (rv1410-11) or  
M. abscessus (MAB_2806-07) and grown in liquid media containing vancomycin. Complementation with operons carrying the inactivating 
DtoN mutations in the respective MFS transporters was performed as well. As a control (Ctrl), wild-type cells (WT), M. smegmatis dKO alone 
(dKO) or complemented with an empty vector were analyzed. [Colour figure can be viewed at wileyonlinelibrary.com]
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(DEER) study of LmrP revealed that this aspartate plays 
a key role in coupling substrate transport to the influx of 
protons (Masureel et al., 2014). We therefore mutated this 
conserved aspartate into asparagine (henceforth called 
DtoN mutation), to obtain an inactive Rv1410 variant that 
is uncoupled from the proton gradient.
Deletion of the lprG-mfs operon in M. abscessus and  
M. smegmatis increases drug susceptibility
Mycobacterium abscessus is a major cause of infec-
tions in cystic fibrosis patients and is notoriously difficult 
to treat because of its intrinsic resistance toward many 
antibiotics including first-line TB drugs (Brown-Elliott 
et al., 2012; Mougari et al., 2016; Rominski et al., 2017; 
Luthra et al., 2018). Genetic deletion of the lprG-mfs 
operon (ΔMAB_2806-07, henceforth called dKO) resulted 
in a pronounced increase of antibiotic susceptibilities 
toward six antibiotics, including tetracycline, rifabutin 
and vancomycin (Table 1). Complementation studies of 
the deletion mutant were carried out using the integrative 
vector pFLAG (Arnold et al., 2018), harboring the coding 
sequences of LprG (MAB_2806), the MFS transporter 
(MAB_2807) or the entire operon under the control of a 
constitutively active promoter. Complementation with the 
entire operon fully rescued the dKO mutant. In contrast, 
MICs were identical to the vector control if the comple-
mentation vector carried LprG alone or the operon with the 
MFS transporter carrying the D82N mutation respectively. 
Interestingly, complementation with the MFS transporter 
alone almost completely reversed drug susceptibility.
The lprG-mfs operon was also deleted in M. smeg-
matis (ΔMSMEG_3069-70, henceforth called dKO), as 
described previously (Farrow and Rubin, 2008), and 
the resulting mutant was found to exhibit increased sus-
ceptibility toward vancomycin, rifabutin and novobiocin 
(Table 2). Complementation with the MSMEG_3069-70 
operon fully reversed drug susceptibility to wild-type level, 
whereas the D72N mutation introduced in the MFS trans-
porter fully abrogated its function. Complementation with 
the MFS transporter MSMEG_3069 partially reversed 
drug susceptibility, but complementation with lprG 
(MSMEG_3070) did not.
In summary, lack of the lprG-mfs operon strongly 
increases intrinsic drug susceptibility in M. abscessus 
and to a lesser degree in M. smegmatis. In both operons, 
the MFS transporters play a dominant role, because their 
expression partially reversed drug susceptibility.
The lprG-mfs operon is highly conserved in 
mycobacteria
High degrees of amino acid identities ranging between 
38–78% for LprG and 63–87% for the MFS transporter 
among different mycobacterial species suggest a con-
served function of the operon (Fig. 1C). In agreement 
with this notion, complementation with the wild-type 
operons from either M. smegmatis, M. tuberculosis 
or M. abscessus fully rescued the growth defect of 
M. smegmatis dKO in the presence of vancomycin, 
rifampicin or novobiocin (Figs 1D and S1). The mutations 
D70N (M. tuberculosis), D72N (M. smegmatis) and 
D82N (M. abscessus) in Rv1410 and its homologues 
fully inactivated the transporters and thus the operon. 
Based on these observations, we decided to study 
the function of M. tuberculosis Rv1410 and LprG in 
M. smegmatis dKO in greater detail.
Periplasmic loop truncations strongly affect function of 
Rv1410
The homology model of Rv1410 predicts a periplasmic 
loop (34 amino acids) between transmembrane helices 
11 and 12, which is not present in published MFS trans-
porter structures. To assess its functional role, we gener-
ated truncation mutants lacking 10, 18, or 26 amino acids 
of the loop respectively (Fig. 2A). The M. smegmatis 
dKO strain was complemented with the operon contain-
ing wild-type LprG and Rv1410 harboring different loop 
truncations, and was subjected to antibiotic susceptibility 
testing. Short and medium loop mutants of Rv1410 were 
as inactive as the deleterious D70N mutant (Fig. 2D–F). 
In contrast, the Rv1410 mutant containing the longest 
loop (i.e. the shortest deletion) was partially active. Its 
residual activity is similar to the one of LprG containing 
the previously described V91W mutation (Drage et al., 
2010) (Fig. 2D–F). Western blot analysis revealed that 
the expression of the loop truncation mutants and wild-
type Rv1410 were equally strong in M. smegmatis (Fig. 
2C). Size exclusion chromatography analysis of purified 
mutant proteins suggested that these mutations did not 
alter the folding behavior of Rv1410 because the mutant 
proteins’ peaks coincided with the peak of wild-type 
Rv1410 on SEC (Fig. 2B, Rv1410 purification is explained 
in more detail in the subsequent section). Together, these 
results support the hypothesis that the periplasmic loop 
is involved in transport processes mediated by Rv1410 
and LprG.
Purified Rv1410 and LprG do not interact
We hypothesized that the periplasmic loop of Rv1410 
may physically interact with LprG, which is known to be 
attached to the outer leaflet of the cytoplasmic mem-
brane via its lipid anchor. To study a potential interaction 
at the biochemical level, we individually expressed and 
purified Rv1410 and LprG. Rv1410 was overexpressed 
in E. coli with a His-tagged GFP fused to its C-terminus. 
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The fusion protein was purified via the His-tag using the 
detergent β-DDM by immobilized metal ion affinity chro-
matography (IMAC) and GFP was cleaved off using HRV 
3C protease. Subsequently, GFP and the His-tagged 
protease were removed by a reverse IMAC step, result-
ing in highly pure protein (Fig. 3A). Rv1410 was finally 
analyzed by size exclusion chromatography (SEC) and 
eluted as monodisperse peak at a retention volume cor-
responding to a Rv1410 monomer (Fig. 3B, red trace). 
Next, LprG was purified from the cytoplasm of E. coli in 
its non-acylated form as described previously (Drage et 
al., 2010) and eluted at a retention volume correspond-
ing to a monomer from SEC (Fig. 3B, green trace). To 
assess complex formation, Rv1410 and LprG were mixed 
and analyzed by SEC (Fig. 3B, black trace). However, 
we did not observe an early eluting peak, which would 
correspond to the size of the Rv1410–LprG complex 
(Fig. 3B). Since the SEC method is only suited to detect 
high-affinity protein complexes, a SPR experiment was 
performed, which can detect affinities even in the micro-
molar range. To this end, Rv1410 was fused to an Avi-tag 
and purified for enzymatic biotinylation (Cull and Schatz, 
2000) along with an Avi-tagged version of E. coli MdfA, 
which was used as negative control. SPR sensor chips 
were coated with biotinylated Rv1410 and MdfA, and 
purified LprG was injected as analyte at different con-
centrations. When injecting the highest three concen-
trations (22, 65 and 194 μM, respectively), LprG gave 
rise to a binding signal with Rv1410 (Fig. 3C). However, 
the same signal was also obtained with MdfA. Hence, 
the interaction is unspecific and presumably mediated 
through contacts of LprG with the detergent micelle of 
Table 1. MIC determination of M. abscessus dKO (ΔMAB_2806-07).
Strain Antibiotic Tetracycline Vancomycin Rifabutin Clofazimine Novobiocin Ofloxacin
WT Median >128 >128 8 0.25 64 64
Range (128 to >128) (>128) (4–8) (0.25–0.5) (32–64) (32–64)
dKO Median 16 16 1 0.06 1 4
Range (8–16) (8–16) (1) (0.06–0.125) (1–2) (4)
EV Median 16 16 0.5 0.125 0.5 4
Range (8–32) (16–32) (0.25–0.5) (0.06–0.125) (≤0.25–2) (4–8)
c. mfs Median 128 >128 4 0.25 32 32
Range (128 to >128) (128 to >128) (4–8) (0.25–0.5) (32–64) (16–32)
c. lprG Median 16 16 0.5 0.06 1 4
Range (8–16) (8–32) (0.5–2) (0.06–0.125) (≤0.25–2) (4–8)
c. lprG-mfs Median >128 >128 8 0.5 64 32
Range (128 to >128) (128 to >128) (4–8) (0.25–0.5) (32–64) (16–64)
c. lprG-mfs 
DtoN
Median 16 32 0.5 0.06 0.5 4
Range (16–64) (8–32) (0.5–1) (0.06–0.25) (≤0.25–1) (4–8)
Complementation (c.) was carried out with the genes of the lprG-mfs operon from M. abscessus. EV, empty vector control. DtoN, MAB2807 
D82N. MIC values correspond to μg ml–1 of the respective antibiotics used. Shown are the median and range of three biological replicates.
Table 2. MIC determination of M. smegmatis dKO (ΔMSMEG_3069-70).
Strain Antibiotic Tetracycline Vancomycin Rifabutin Clofazimine Novobiocin Ofloxacin
WT Median 0.5 256 4 0.5 32 0.5
Range (0.5) (256–512) (4–8) (0.5) (32) (0.5)
dKO Median 0.25 16 0.25 0.5 4 0.5
Range (0.25–0.5) (8–16) (0.125–0.5) (0.5) (4) (0.5)
EV Median 0.5 32 0.125 0.5 4 0.5
Range (0.25–0.5) (32) (0.125–0.25) (0.5) (4–16) (0.5)
c. mfs Median 0.5 64 1 0.5 8 0.5
Range (0.5) (64–128) (0.5–1) (0.5) (8) (0.5)
c. lprG Median 0.5 32 0.25 0.5 4 0.5
Range (0.25–0.5) (16–32) (0.25–0.5) (0.5) (4) (0.5)
c. lprG-mfs Median 0.5 512 4 0.5 16 0.5
Range (0.5–1) (256–512) (4–8) (0.5–1) (16–32) (0.5)
c. lprG-mfs 
DtoN
Median 0.5 16 0.5 0.5 4 0.5
Range (0.5) (16) (0.25–0.5) (0.5) (4–8) (0.5–1)
Complementation (c.) was carried out with the genes of the lprG-mfs operon from M. smegmatis. EV, empty vector control. DtoN, MSMEG3069 
D72N. MIC values correspond to μg ml–1 of the respective antibiotics used. Shown are the median and range of three biological replicates.
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purified Rv1410 and MdfA. In summary, our biophysical 
experiments revealed that Rv1410 and LprG do not form 
a complex, at least not outside of the membrane context.
Lack of lprG-mfs operon leads to increased drug influx
M. abscessus and M. smegmatis dKO mutants were 
clearly more susceptible toward vancomycin, a drug 
which acts in the periplasm as a cell wall synthesis 
inhibitor (Perkins, 1969). Importantly, vancomycin does 
not need to enter the cytoplasm to inhibit cellular growth, 
and consequently, possible transport of vancomycin 
across the cytoplasmic membrane mediated by Rv1410 
would not result in increased resistance toward this 
drug. This made us question the transporter’s role as a 
drug efflux pump, which has been repeatedly proposed 
in the literature (Silva et al., 2001; Ramon-Garcia et al., 
2009). We hypothesized that higher permeability of the 
Fig. 2. Functional analysis of Rv1410’s periplasmic loop.  
A. Periplasmic loop sequence of wild-type Rv1410 (residues 430–463) and the three loop truncations.  
B. Rv1410 with the respective loop truncations were purified from E. coli and separated by SEC. Purified wild-type Rv1410 served as 
reference.  
C. Production levels of loop truncations of Rv1410 expressed in M. smegmatis dKO using complementation vector pFLAG were probed by 
Western blotting via a C-terminal 3xFLAG tag. M. smegmatis dKO harboring the empty pFLAG vector served as negative control.  
M. smegmatis dKO expressing full-length Rv1410 (WT) and Rv1410 D70N served as positive control.  
D–F. M. smegmatis dKO complemented with empty vector, the wild-type lprG-rv1410 operon of M. tuberculosis and the operon containing 
mutations in rv1410 (loop truncations and D70N) or lprG (V91W) was grown in the presence of vancomycin (D), rifampicin (E) and novobiocin 
(F). The growth curves are representative of three biological replicates and error bars denote the standard deviation of four to six technical 
replicates. [Colour figure can be viewed at wileyonlinelibrary.com]
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cell envelope due to the lack of transport of LAMs, TAGs 
and presumably additional triacylated lipids to their cor-
rect locations could cause increased influx of drugs. We 
tested the hypotheses of drug efflux mediated by Rv1410 
(Fig. 4A) and increased drug influx via a defective cell 
wall (Fig. 4B) by monitoring the accumulation of fluores-
cent substrates (ethidium, BCECF-AM, calcein-AM) in 
energized and de-energized cells.
As a positive control, we included the well-studied 
ethidium efflux pump LfrA of M. smegmatis (Sander 
et al., 2000; Rodrigues et al., 2011). Akin to Rv1410, 
LfrA is a DHA2 family MFS transporter with 14 trans-
membrane helices. In the presence of the proton-motive 
force (cells energized with glucose), we observed more 
accumulation of ethidium in the ∆lfrA strain compared 
to the wild-type strain (Fig. 4C). However, when the 
cells were de-energized with the protonophore CCCP, 
a rise in the accumulation of ethidium was observed in 
both strains, resulting in comparable accumulation lev-
els (Fig. 4C). Hence, in the absence of the proton-mo-
tive force, LfrA and other active transporters mediating 
ethidium efflux lose their ability to extrude ethidium and 
thus the wild-type strain displays a phenotype identical 
to the ∆lfrA strain.
Similar results would be expected if Rv1410 and LprG 
formed a drug efflux system. However, M. smegmatis 
dKO accumulated more BCECF and calcein than wild-
type cells, regardless whether they were in an energized 
or de-energized state (Figs 4D and S2A). This observa-
tion suggests that the dKO strain exhibits an increased 
Fig. 3. Interaction studies of purified Rv1410 and LprG.  
A. SDS-PAGE analysis monitoring the purification of Rv1410 expressed in E. coli. The following samples were loaded on the gel: (1) 
solubilized total membrane proteins, (2) elution from IMAC containing mainly His-tagged Rv1410-GFP fusion protein, (3) IMAC flow-through 
using wash buffer, (4) after cleavage with 3C protease, (5) flow-through of reverse IMAC after 3C cleavage containing tag-less Rv1410, (6) 
elution of reverse IMAC containing His-tagged GFP and His-tagged 3C protease, (7) highly pure Rv1410 after SEC.  
B. Analytical SEC using purified Rv1410 alone (red trace), LprG alone (green trace) and Rv1410 and LprG mixed at a 1:5 molar ratio (black 
trace).  
C. SPR analysis of Rv1410-LprG interaction. Rv1410 and control protein MdfA were immobilized and purified LprG served as analyte. [Colour 
figure can be viewed at wileyonlinelibrary.com]
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dye permeability compared to wild-type cells. Hence, 
the data support the hypothesis that Rv1410 and LprG 
transport lipids required for the proper biogenesis of the 
mycobacterial outer membrane, which remained unaf-
fected by the addition of CCCP within the short time-
frame of our experiments (Fig. 4B). Of note, BCECF and 
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calcein fluorescence levels were in general lower under 
de-energized conditions due to the dependence of dye 
fluorescence on pH (Ozkan and Mutharasan, 2002; 
Boens et al., 2006). When CCCP was added to cells 
energized with glucose, an immediate drop in fluores-
cence intensity was detected for BCECF (Fig. 4E) and 
calcein (Fig. S2B), respectively. This drop was caused 
by a sudden decrease of the cytoplasmic pH upon dis-
sipation of the proton motive force and shows that sub-
stantial amounts of BCECF-AM and calceine-AM were 
converted into their fluorescent forms by intracellular 
esterases.
In conclusion, our data strongly support the hypothesis 
that Rv1410 and LprG contribute to the integrity and low 
permeability of the mycobacterial cell envelope by trans-
porting important lipid constituents. Further, direct experi-
mental evidence is provided suggesting that Rv1410 does 
not export fluorescent substrates out of the cell.
Rv1410 does not mediate drug efflux in L. lactis
To further corroborate the lacking drug efflux activity of 
the MFS transporter, we expressed the rv1410 gene of 
M. tuberculosis in the Gram-positive bacterium L. lactis, 
which is a widely used model system to investigate drug 
efflux pumps (Seeger et al., 2012; Hürlimann et al., 2016). 
First, we confirmed that the bona fide efflux pumps LmrP 
and MdfA actively export the dyes ethidium, Hoechst 
33342 and in case of LmrP BCECF-AM (Figs 5, S3A and 
B). Wild-type transporters were expressed along with the 
respective controls containing the inactivating DtoN muta-
tion. BCECF-AM, ethidium or Hoechst 33342 was added 
to the washed cells in a glucose-containing buffer and 
the fluorescence arising from dye uptake was recorded. 
In this experimental setup, active dye efflux results in a 
slower rise of fluorescence. As expected, strong differ-
ences between bacteria expressing wild-type transporters 
and the respective DtoN mutants were observed for 
BCECF-AM (LmrP, Fig. 5B), ethidium (LmrP and MdfA, Fig. 
S3A) and Hoechst 33342 (LmrP, Fig. S3B), confirming that 
these proteins are drug efflux pumps. By contrast, under 
the same experi mental conditions Rv1410 and Rv1410 
D70N exhibited nearly identical fluorescence traces (Figs 
5A, S3A and B), showing that Rv1410 appears to be unable 
to transport these dyes, which are common substrates for 
multidrug efflux pumps. Further, we determined the minimal 
Fig. 4. Functional investigation of Rv1410 in M. smegmatis.  
A and B. Two hypotheses predicting the functional outcome of a transport experiment assuming that Rv1410 is a drug efflux pump (A) or a 
lipid transporter (B). Gray circles represent non-fluorescent BCECF-AM, which is converted by intracellular esterases into fluorescent BCECF 
(yellow stars). Drug efflux pumps (here Rv1410) export BCECF-AM prior to esterase cleavage. Addition of CCCP disrupts the proton gradient 
across the inner membrane and thereby inactivates Rv1410.  
C. Ethidium transport in M. smegmatis mediated by the bona fide drug efflux pump LfrA, which follows the hypothesis shown in panel A. 
Ethidium was added to washed cells under energized (Glc) and de-energized (CCCP) conditions and ethidium uptake into the cell was 
monitored by fluorescence of ethidium intercalated into chromosomal DNA.  
D. BCECF-AM transport in M. smegmatis wild-type and dKO cells, which follows the hypothesis shown in panel B. Non-fluorescent BCECF-
AM was added to washed cells under energized (Glc) and de-energized (CCCP) conditions and was converted into fluorescent BCECF by 
intracellular esterases.  
E. Traces of BCECF-AM uptake of energized (Glc) and de-energized (CCCP) cells are shown as in panel D. In addition, BCECF-AM uptake 
traces were recorded, in which CCCP was added to energized cells at time point 480 s (dotted lines, Glc-CCCP). CCCP addition leads to 
an immediate decrease of BCECF fluorescence, because the proton-motive force is eliminated resulting in a drop of intracellular pH. For 
the traces shown in panels C and D, average fluorescence intensities and 95% confidence intervals using a Student’s t distribution were 
calculated from the data of six biological replicates. [Colour figure can be viewed at wileyonlinelibrary.com]
Fig. 5. BCECF-AM efflux mediated by Rv1410, LmrP and MdfA expressed in L. lactis. BCECF-AM was added to the washed L. lactis cells 
expressing wild-type Rv1410 (A), LmrP (B) and MdfA (C) or transporters carrying the corresponding DtoN mutations. BCECF accumulation in the 
cytosol was monitored by fluorescence. Only LmrP exhibits BCECF-AM efflux activity. [Colour figure can be viewed at wileyonlinelibrary.com]
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inhibitory concentration for vancomycin, rifampicin and 
novobiocin using L. lactis cells expressing Rv1410, but did 
not find any difference between cells expressing the wild-
type transporter versus the corresponding DtoN mutant 
(Fig. S3C). In order to assess expression levels, we fused 
GFP to the C-termini of the transporters and could show 
by in-gel fluorescence that all three transporters, including 
Rv1410, were well expressed (Fig. S3D). Of note, LmrP-
GFP and MdfA-GFP were still capable of dye transport, 
whereas no efflux activity was observed for Rv1410-GFP 
(not shown). The lipid composition of L. lactis membranes 
is different from mycobacteria, which may cause incor-
rect folding and aggregation of the transporter. However, 
overexpressed Rv1410 purified from L. lactis membranes 
via its His-tag eluted as monodisperse peak from SEC at 
a retention volume corresponding to the size of a Rv1410 
monomer, thereby excluding major folding and aggregation 
issues (Fig. S3E). In summary, Rv1410 is well expressed 
and properly folded in L. lactis, but lacks drug efflux activity.
M. smegmatis dKO cells are more rigid
We hypothesized that deletion of the lprG-mfs operon 
might also affect the mechanical properties of the cell 
surface and therefore investigated wild-type and dKO 
cells by AFM. Wild-type and dKO cells were mixed and 
imaged using correlated optical fluorescence micros-
copy (OFM) and AFM (Eskandarian et al., 2017). 
Fluorescently labeled Wag31 was expressed in the wild-
type cells to distinguish them from dKO cells (Santi et al., 
2013). Control experiments in which the dKO mutant was 
labeled with fluorescent Wag31 excluded the possibility 
that fluorescent protein expression affected the experi-
mental outcome. The mean surface rigidity, represented 
as the elastic modulus, was calculated for wild-type and 
dKO cells from images obtained by AFM (Fig. 6A and B). 
Interestingly, the mean surface rigidity of the dKO mutant 
was found to be significantly higher than in wild-type 
cells (Fig. 6C).
M. smegmatis dKO has a cell separation defect
We used transmission electron microscopy (TEM) to 
investigate whether lack of the lprG-mfs operon influ-
ences cellular morphology. Interestingly, we noticed a 
cell separation defect as manifested by long cell chains 
divided by multiple septa (Fig. 7A), which appeared to 
be more prevalent in M. smegmatis dKO. In order to 
quantify this defect, we used fluorescence microscopy 
to analyze mycobacterial cells that were stained with 
the membrane dye SynaptoRed. In addition, the cells 
expressed the Wag31–GFP fusion protein, which local-
izes to septa formed during cell division and remains 
attached to the poles (Santi et al., 2013) (Fig. 7B). 
Overall, 1105 cell chains were counted. Because the 
experiments and data analysis were conducted blinded, 
the number of dKO strain and wild-type strain differed 
by a factor of around 2 (Fig. 7C). Upon data normaliza-
tion, we observed 3 times more chains consisting of 
three or more cells in the dKO strain compared to the 
wild-type strain (Fig. 7D). Pearson’s χ2
 test showed sig-
nificant difference in the distribution of the cell chains 
of different lengths between wild-type and dKO strains 
Fig. 6. Analysis of cell surface rigidity of M. smegmatis by 
correlated optical fluorescence and AFM.  
A. AFM images of representative wild-type and dKO cells are 
depicted in 3D with the AFM stiffness (DMT modulus) image 
overlaid as a skin on top of the AFM height image. Cell profiles 
were harvested from AFM images by drawing a segmented line 
along the midline of the cell length along which the AFM height (B, 
top panel) as well as the DMT modulus providing a measure for 
cell surface rigidity (B, bottom panel) were plotted.  
C. Violin plot of the average DMT modulus of wild-type (n = 162) 
and dKO (n = 90) cells. The horizontal black bars represent the 
median DMT modulus, the boxes correspond to the interquartile 
ranges, the straight vertical lines contain all data points except of 
the outliers marked as dots. Two-sided Wilcoxon rank sum test 
identified statistically significant location shift between WT and 
dKO samples with a p-value of 1.02 × 10–14. [Colour figure can be 
viewed at wileyonlinelibrary.com]
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(χ2 = 7.3571, df = 2, p-value = 0.02526). These results 
suggest the presence of a cell separation defect after 
the cell division event. The extent of the cell separation 
defect was probably underestimated, because long cell 
chains are more likely to become entangled in cell clus-
ters which were excluded from data analysis.
Discussion
Rv1410 and its operon partner LprG have been the 
subject of numerous studies in past years. Whereas 
LprG’s role is to bind triacylated lipids such as LAMs, 
PIMs and TAGs, Rv1410 was proposed to possess a 
Fig. 7. M. smegmatis cells lacking the lprG-mfs operon have a cell separation defect.  
A. Transmission electron microscopy image of a M. smegmatis dKO cell chain divided by multiple septa.  
B. Exemplary 3D fluorescence microscopy image of M. smegmatis dKO cells stained with SynaptoRed membrane dye and expressing the 
Wag31-GFP fusion proteins localizing at septa and cell poles. Such images were used to quantify the cell separation defect.  
C. Distribution of the number of cells per chain of wild-type (n = 379) and dKO (n = 726) cells.  
D. Normalized distribution of the number of cells per chain of wild-type and dKO cells, in which >3 cells per chain are summarized in one bar. 
Pearson’s χ2 test showed significant difference in the distribution of the cell chains (χ2 = 7.3571, df = 2, p-value = 0.02526). [Colour figure can 
be viewed at wileyonlinelibrary.com]
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dual function, namely drug efflux as well as lipid trans-
port (Farrow and Rubin, 2008; Ramon-Garcia et al., 
2009). In this work, we observed that deletion of the 
lprG-mfs operon in M. smegmatis and M. abscessus 
resulted in a marked increase of vancomycin, rifampi-
cin/rifabutin and novobiocin susceptibility, a result that 
is in full agreement with a previous study on M. bovis 
BCG (Ramon-Garcia et al., 2009). While rifampicin/
rifabutin and novobiocin target intracellular proteins, 
vancomycin has its target in the periplasm. Importantly, 
periplasmic vancomycin concentrations solely depend 
on the diffusion across the outer membrane, and con-
sequently, Rv1410-mediated vancomycin export across 
the inner membrane cannot account for vancomycin 
resistance. Rather, the activity of Rv1410 appears to be 
required for the correct assembly of the mycobacterial 
outer membrane. In further support of this notion, cells 
lacking the operon were found to accumulate more 
BCECF and calcein dyes, irrespective whether they 
were in an energized or de-energized state. Hence, 
active dye efflux mediated by Rv1410, which depends 
on the proton-motive force, cannot explain this obser-
vation. Finally, Rv1410 expressed in L. lactis did not 
exhibit efflux activity toward BCECF-AM, ethidium and 
Hoechst 33342, nor did it confer resistance toward van-
comycin, rifampicin or novobiocin, despite of the fact 
that the transporter was expressed at high levels and 
well folded.
We show in this work that Rv1410 critically depends on 
the proton-motive force, because substitution of a con-
served aspartate by asparagine (DtoN mutation), a resi-
due coupling substrate transport to the influx of protons, 
completely abrogated Rv1410’s capacity to confer resis-
tance toward all drugs tested, including the periplasmic 
drug vancomycin. Hence, inclusion of protonophores in 
the growth medium does not only inhibit the potential drug 
efflux activity of Rv1410, but also its lipid transport activity 
and consequently the correct assembly of the outer mem-
brane during the long growth period. Therefore, previous 
experiments performed in the presence of sub-inhibitory 
CCCP concentrations from which it was concluded that 
Rv1410 is an efflux pump for rifampicin and novobiocin 
are likely ambiguous (Ramon-Garcia et al., 2009). In order 
to differentiate between drug and lipid transport activity 
mediated by Rv1410, we chose an experimental design in 
which we added CCCP to washed cells shortly prior to the 
addition of the dyes BCECF-AM or calcein-AM. Thereby 
we avoided defects of the outer membrane and were able 
to truly distinguish drug influx from drug efflux. These 
experiments clearly revealed that increased BCECF and 
calcein accumulation in mutant cells is solely attributable 
to increased influx, unequivocally suggesting an outer 
membrane defect resulting in increased dye permeability. 
It is interesting to note that certain mutations affecting the 
lipopolysaccharide (LPS) biosynthesis of Gram-negative 
bacteria exhibit drug susceptibility profiles that are very 
similar to the lprG-mfs operon deletion mutants observed 
here and in M. bovis BCG (Ramon-Garcia et al., 2009). 
Most prominent in this context are the lpxC (originally 
called envA) mutations in E. coli, which are defective in 
Lipid A biosynthesis resulting in periplasmic leakage of 
proteins and higher susceptibility toward larger drugs 
including rifampicin, novobiocin and vancomycin, that 
cannot be transported through outer membrane porins 
(Young and Silver, 1991; Young et al., 1995; Nikaido, 
2005).
In addition to the increased outer membrane permea-
bility, we observed a cell separation defect in M. smeg-
matis lacking the operon, as manifested by long chains 
of cells separated by already formed septa. Interestingly, 
such chain-forming phenotypes displaying septation and 
cell separation defects have been described for several 
Gram-negative bacterial mutants containing a defective 
outer membrane (Normark et al., 1969; Weigand et al., 
1976; Stanley et al., 2001).
Using state-of-the-art AFM, we could demonstrate that 
the cell surface of the deletion mutants is significantly 
more rigid. At first sight, a connection between increased 
membrane stiffness and higher permeability appears 
counterintuitive. Indeed, AFM studies on isolated mem-
brane vesicles with defined lipid compositions revealed 
that membranes of higher rigidity are less permeable 
for calcein (Takechi-Haraya et al., 2017). However, lipid 
vesicles are several orders of magnitude softer than the 
complex mycobacterial outer membrane, suggesting that 
the physical principle underlying membrane permeabil-
ity differs among them. Interestingly, an E. coli mutant 
unable to incorporate unsaturated fatty acid chains into 
lipid A became hypersusceptible toward vancomycin and 
rifampicin at 12°C, but not at 30°C, indicating that large 
drugs can enter the periplasm through a stiffened outer 
membrane (Vorachek-Warren et al., 2002). Our results 
suggest that lack of the lprG-mfs operon results in a rigid-
ified mycobacterial outer membrane, which might contain 
imperfections and ‘cracks’ through which large drugs and 
dyes gain access to the periplasm.
The aggregated data on Rv1410 and LprG as outlined 
in previous works and here clearly suggest that these 
proteins form a tandem responsible for the transport of 
triacylated lipids for the correct biogenesis of the outer 
mycobacterial membrane (Fig. 8). But how do they work 
in concert? In this study, we showed that the MFS trans-
porter plays the dominant role of the duo, because its 
expression as solitary protein in M. smegmatis and in 
particular in M. abscessus to a large degree reversed 
drug susceptibility. It is thus conceivable that Rv1410 and 
its mycobacterial orthologues can cooperate with lipo-
proteins other than LprG, which may partially substitute 
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LprG’s function. In support of this view, we observed that 
purified Rv1410 and LprG do not physically interact with 
each other, at least not via a classical protein-protein 
interaction that can be observed outside of the membrane 
context. LprG was proposed to be responsible for the 
shuttling of triacylated lipids across lipid membranes, as 
was shown in biochemical in vitro experiments (Martinot 
et al., 2016). In the same study, the role of Rv1410 was 
proposed to flip TAGs and presumably other triacylated 
lipids across the inner membrane (Martinot et al., 2016). 
However, functional evidence supporting this hypothe-
sis is currently lacking. Given the fact that rv1410 and its 
orthologues are nonessential genes, it is unlikely that this 
MFS transporter is the only protein responsible for such 
a crucial transport activity. In analogy to the E. coli Lpt 
pathway of LPS transport, in which the ABC transporter 
LptB2FG extracts LPS from the outer leaflet of the cyto-
plasmic membrane in an ATP-dependent fashion to be 
transferred to periplasmic LPS shuttling proteins (Okuda 
et al., 2016), Rv1410 may be required to extract TAGs, 
LAMs and other triacylated lipids from the outer leaflet of 
the inner mycobacterial membrane and deliver them to 
LprG (Fig. 8). In such a model, Rv1410’s role is to charge 
LprG with a substrate. The conspicuous periplasmic loop 
between TM11 and TM12 may play a role in transferring 
lipids to LprG, because its deletion abrogates the function 
of the operon. It should be noted that LprG is a lipopro-
tein, which is anchored in the outer leaflet of the cytoplas-
mic membrane via three acyl-chains. It is therefore also 
imaginable that Rv1410’s role is to extract LprG from the 
membrane to send it on its journey across the periplasm 
to the outer membrane to deliver its cargo lipids. In E. 
coli, the ABC transporter LolCDE powers the extraction 
of the lipoprotein from the inner membrane using the 
energy of ATP and delivers it to the periplasmic shuttling 
protein LolA (Yakushi et al., 2000). Currently, these pos-
sible mechanisms of Rv1410 are purely speculative and 
detailed biochemical in vitro studies are needed to further 
address the important question of how Rv1410 and LprG 
work in concert to shuttle lipids from the inner to the outer 
mycobacterial membrane.
Experimental procedures
Bacterial strains and growth conditions
Mycobacterium smegmatis mc2 155 and Mycobacterium 
abscessus (ATCC19977T) were used in this study. 
Mycobacteria were grown at 37°C in liquid Middlebrook 7H9 
medium containing 0.05% Tween 80 or on solid Middlebrook 
7H10 medium supplemented with OADC containing 4.5 ml 
L–1 glycerin. Escherichia coli MC1061, the strain used during 
cloning and for heterologous protein expression, was grown 
in lysogeny broth medium (LB) or Terrific broth medium 
(TB) at 37°C or 25°C respectively. Lactococcus lactis ΔlmrA 
ΔlmrCD (Venter et al., 2008) was grown in M17 medium sup-
plemented with 0.5% glucose (GM17) at 30°C without shak-
ing (Hürlimann et al., 2016). Where required, the medium 
was supplemented with the following amounts of antibiotics: 
100 μg ml–1 of ampicillin (Amp100), 5 or 25 μg ml–1 of chlor-
amphenicol (Cm5/Cm25) for L. lactis and E. coli, respec-
tively, 25 μg ml–1 of apramycin (Apr25) for M. smegmatis or 
50 μg ml–1 apramycin (Apr50) for E. coli and M. abscessus, 
and 32 μg ml–1 isoniazid for M. abscessus.
Gene deletion of lprG-mfs (MSMEG_3069-70) and lfrA 
(MSMEG_6225) in M. smegmatis
Gene deletions in M. smegmatis mc2 155 were gener-
ated by a two-step recombination approach. The flanking 
regions of the respective genetic loci were amplified by PCR 
from genomic DNA (gDNA) using primers listed in Table 
S1. Both fragments were purified via agarose gel, cut with 
BspQI, cloned in one step into pINIT (Cm25) using fragment 
exchange (FX) cloning (Geertsma and Dutzler, 2011). After 
sequencing, the fragments were cut from pINIT and cloned 
into the mycobacterial suicide vector pKO, which was propa-
gated in E. coli using Apr50 (Arnold et al., 2018). For the first 
recombination step, the pKO vectors carrying the flanking 
regions were transformed into M. smegmatis by electropo-
ration and plated on 7H10 plates containing Apr25. Colonies 
appeared after 3–4 days incubation and were grown in 
5 ml liquid 7H9 (Apr25) for 2–3 days. gDNA was isolated 
(GenElute™ Bacterial Genomic DNA Kit, Sigma) and was 
analyzed by PCR for 5′ and/or 3′ integration. PCR-positive 
clones were grown in liquid 7H9 medium devoid of apra-
mycin for 2–3 days and 1 μl was plated on 7H9 plates con-
taining 0.5% 2-Deoxy-Galactose (2-DOG) and 10% sucrose 
for counterselection. Colonies were resuspended in 10 μl 
Fig. 8. Hypothetical mechanisms of lipid transport mediated 
by Rv1410 and LprG. 1. Rv1410 may transport TAGs (red) and 
LAM precursors across the plasma membrane. 2. Rv1410 
may flip TAGs from the inner to the outer leaflet of the plasma 
membrane. 3. Rv1410 may extract TAGs from the outer leaflet of 
the plasma membrane and deliver them to LprG. 4. Rv1410 may 
extract the lipid anchor of LprG from the outer leaflet to facilitate 
LprG-mediated TAG transport to the outer membrane. PG: 
peptidoglycan, AG: arabinogalactan, MA: mycolic acids. [Colour 
figure can be viewed at wileyonlinelibrary.com]
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dH2O and screened by PCR to differentiate between gene 
deletions or wild-type revertants. gDNA of identified gene 
deletion mutants was isolated to confirm gene deletions by 
PCR and the strains were tested for susceptibility toward 
apramycin.
Gene deletion of lprG-mfs (MAB_2806-07) in  
M. abscessus ATCC19977T
To construct the gene deletion mutant, gene deletion vector 
pSE-arp-katG-∆lprG-∆MAB_2807 was generated. To this 
end, a 1526 bp fragment upstream of the target genes was 
amplified by PCR with the primers MAB_2806/07_5′_for 
and MAB_2806/07_5′_rev and a 1467 bp fragment down-
stream of the genes with the primers MAB_2806/07_3′_for 
and MAB_2806/07_3′_rev (primer sequences are found in 
Table S1). The primers were appended with PscI, XbaI or 
HindIII recognition sites (underlined in Table S1). The PCR 
fragments were first cloned into pGEM-T easy (Promega), 
from which they were cut using the corresponding restriction 
enzymes and successively cloned into the linearized pSE-
apr-katG vector to result in the final gene deletion suicide 
vector pSE-arp-katG-∆lprG-∆MAB_2807. The vector was 
transformed into M. abscessus ATCC 19977T as previously 
described (Rominski et al., 2017). Putative single cross-over 
colonies were selected on Apr50 and confirmed by Southern 
blotting. Double cross-over recombinants were subse-
quently selected on isoniazid (32 μg ml–1) and confirmed by 
Southern blotting (Rominski et al., 2017).
Gene cloning into the FX cloning initial vector pINIT
All expression constructs were generated using the FX 
cloning method (Geertsma and Dutzler, 2011), which was 
recently expanded with a vector series suitable for myco-
bacteria (Arnold et al., 2018). As a first step, the open 
reading frames of interest were cloned into an initial vector 
(pINIT, Cm25), sequenced and then used for sub-cloning 
by fragment exchange into the required destination vectors 
(see below). Using primers specified in Table S2, Q5 High-
Fidelity DNA polymerase (NEB) and if not stated otherwise 
genomic DNA (gDNA) as template, the following genes were 
amplified. (1) The lprG-mfs operons and its single genes of 
M. smegmatis mc2 155, M. abscessus ATCC19977T (gDNA) 
and M. tuberculosis H37Rv (bacmid library as PCR tem-
plate (Brosch et al., 1998)); (2) a truncated version of lprG 
called lprG_trunc without signal sequence and lipobox as 
described previously (Drage et al., 2010) from M. tubercu-
losis for cytoplasmic expression; (3) lmrP from L. lactis; (4) 
mdfA from E. coli. PCR products were purified via agarose 
gel, cut with BspQI and cloned into pINIT using chemically 
competent E. coli MC1061 cells. The ORFs in the resulting 
pINIT constructs were completely sequenced. Mutations 
in the lipoprotein or the MFS transporter genes (pINIT) 
were introduced using the QuikChange site-directed muta-
genesis protocol (primers listed in Table S3). Rv1410 loop 
truncations were generated by PCR amplification of pINIT_
rv1410-11 (for complementation) or pINIT_rv1410 (for protein 
expression and purification) using primers listed in Table 
S3, resulting in a large blunt-ended PCR product lacking 
the nucleotides encoding for the loop. The PCR products 
were treated with DpnI (NEB), ligated with T4 ligase (Thermo 
Scientific), and transformed into E. coli MC1061. Loop trun-
cations were confirmed by sequencing.
Cloning of transporters for expression in L. lactis
Transporters genes encoding for Rv1410, LmrP and MdfA 
and the corresponding DtoN mutants were sub-cloned from 
the pINIT constructs into E. coli vectors pREXC3H and 
pREXC3GH (Geertsma and Dutzler, 2011) and from there 
via vector-backbone exchange (VBEx) cloning into the L. 
lactis expression vector pNZ8048, which is under the con-
trol of the nisin-inducible promoter (Geertsma and Poolman, 
2007). For transport experiments, the transporters were 
cloned into pNZ8048 via vector pREXC3H, resulting in a 
fusion of a HRV 3C protease cleavage site and a His10-tag 
to the C-termini of the proteins. For protein detection and 
purification, cloning into pNZ8048 via pREXC3GH was per-
formed, which adds a 3C site, a GFP and His10-tag to the 
C-terminus of the expressed transporters.
Construction of mycobacterial complementation vectors
For complementation, the integrative mycobacterial vector 
pFLAG was used (Arnold et al., 2018). It contains a con-
stitutive tet-promoter and adds a 3xFLAG sequence to the 
C-terminus of the cloned genes for detection by Western 
blotting. The lprG-mfs operons, its single genes as well as 
site directed mutants and loop truncation mutants were sub-
cloned from pINIT (see above) into pFLAG and propagated 
in E. coli (Apr50). The resulting pFLAG expression vectors 
were integrated into the genome of M. smegmatis ΔlprG-
mfs (∆MSMEG_3069-70) by co-electroporation with suicide 
plasmid pMA_Int harboring the L5 bacteriophage integrase 
(Arnold et al., 2018). Cells were plated on 7H10 (Apr25) and 
colonies were picked and grown in 7H9 (Apr25). Of note, 
because pFLAG does not contain the integrase gene, the 
integration is stable also in the absence of the selection 
marker apramycin (Springer et al., 2001).
Western blotting to detect loop mutant production in  
M. smegmatis
Cultures of M. smegmatis dKO complemented with empty 
vector pFLAG, and pFLAG harboring Rv1410, Rv1410 
D70N, or the three Rv1410 loop truncation mutants were 
grown into stationary phase. The OD600 of the cultures were 
adjusted to an identical value and harvested. The cell pellets 
were resuspended in 500 μl 20 mM Tris/HCl pH 8, 200 mM 
NaCl, a spatula tip of acid-washed glass beads ≤106 μm 
(Sigma) was added, and then the cells were lysed with a 
FastPrep-24 Classic cell lysis machine (MP Biomedicals) 
for 3 cycles of 60 s at 6 m s–1. The lysate was spun 5 min 
at 8,000 rpm at 4°C with a F-45-30-11 rotor (Eppendorf) to 
pellet glass beads and cell debris. 100 μl of supernatant 
were mixed with 25 μl of 5x SDS loading dye (120 mM Tris/
HCl pH 6.8, 50% glycerol, 100 mM DTT, 2% SDS (w/v), 
0.1% bromophenol blue (w/v)), of which 10 μl were loaded 
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on a 4%–20% SDS-PAGE gel (ExpressPlusTM PAGE gel, 
Genscript). Separated proteins were transferred to a mem-
brane (Immobilon-PSQ, Merck) by soaking the gel and 
membrane in transfer buffer (2.9 g glycine, 5.8 g Tris, 0.1% 
SDS (w/v) and 20% methanol (v/v) in 1 liter), and trans-
ferring with a Trans-Blot® SD Semi-Dry Electrophoretic 
Transfer Cell (BIO-RAD) for 1 h at 12 V. Then the membrane 
was blocked in PBS buffer containing 5% (w/v) milk powder 
and 0.05% (v/v) Tween20 for 1 h at RT, incubated in block-
ing buffer with anti-FLAG antibody (Sigma, F3165) diluted 
1:10,000 (v/v) for 1h at RT while rotating, and washed 3× 
with washing buffer (PBS containing 0.05% (v/v) Tween20). 
The membrane was incubated with α-mouse-HRP antibody 
(Sigma, A5278) diluted 1:30,000 (v/v) for 1 h at RT, washed 
again 3 times with washing buffer. The proteins were visu-
alized by adding Immobilon Western Chemiluminescent 
HRP Substrate (Merck) and measuring chemiluminescence 
using ImageQuant LAS 4000 (GE Healthcare).
Construction of E. coli vectors for the expression of 
Rv1410, LprG_trunc, Rv1410-AviC and MdfA_AviC
By subcloning genes from pINIT (see above), the following 
arabinose-inducible pBX-vectors (Geertsma and Dutzler, 
2011) for protein expression and purification were con-
structed: (1) pBXC3H_LprG_trunc encoding for LprG_trunc 
(no signal sequence and lipobox, as described in (Drage 
et al., 2010))/3C protease-cleavage site/His10-tag, (2) pBX-
C3GH_Rv1410 encoding for Rv1410/3C/GFP/His10-tag, (3) 
pBXCA3GH_Rv1410 encoding for Rv1410/Avi-tag/3C/GFP/
His10-tag and (4) pBXCA3GH_MdfA encoding for MdfA/Avi-
tag/3C/GFP/His10-tag. The latter two constructs contain an 
Avi-tag for enzymatic biotinylation after protease cleavage 
(Bukowska et al., 2015).
Expression and purification of M. tuberculosis Rv1410 
and LprG_trunc
E. coli MC1061 precultures harboring pBXC3GH_Rv1410 
or pBXC3H_LprG_trunc were directly inoculated from 
glycerol stocks in LB, Amp100 and grown at 37°C overnight. 
The precultures were diluted 1:40 (v/v) into fresh expres-
sion medium (TB, Amp100) and grown for 2 h at 37°C and an 
additional hour at 25°C before induction of protein expres-
sion with 0.002% L-arabinose overnight. Cells were har-
vested for 20 min at 6,000 rpm in a Fiberlite F10-4x1000 
LEX centrifuge rotor at 4°C. Membranes were prepared by 
disrupting the cells with a Microfluidizer (Microfluidics) at 
30 kpsi in 20 mM Tris/HCl pH 8.0, 200 mM NaCl supple-
mented with 3 mM MgSO4 and traces of DNaseI on ice. 
In case of Rv1410, unbroken cells and cell debris were 
removed by centrifugation for 30 min at 8,000 rpm in a 
Sorvall SLA-1500 rotor at 4°C. Membranes were collected 
in a Beckman Coulter ultracentrifuge using a Beckman 
Ti45 rotor at 38,000 rpm for 1 h at 4°C and resuspended 
in TBS (pH 7.5) containing 10% glycerol. Membranes were 
solubilized for 2 h using 1% β-DDM (w/v); insolubilized 
material was removed by ultracentrifugation. The super-
natant was loaded on Ni2+-NTA columns, washed with 
50 mM imidazole (pH 7.5), 200 mM NaCl, 10% glycerol, 
0.03% β-DDM and eluted with 200 mM imidazole (pH 7.5), 
200 mM NaCl, 10% glycerol, 0.03% β-DDM. In order to 
remove the C-terminally attached GFP/His10-Tag the buf-
fer of the protein preparation was first exchanged (20 mM 
Tris/HCl pH 7.4, 150 mM NaCl, 0.03% β-DDM) via a PD-10 
desalting column. In a second step 3C protease cleavage 
was performed overnight. In case of LprG_trunc, unbro-
ken cells and cell debris were removed by centrifugation 
for 30 min at 15,000 rpm in a Beckman Coulter ultracentri-
fuge at 4°C using a Beckman Ti45 rotor. The supernatant 
was loaded on Ni2+-NTA columns, washed with 50 mM 
imidazole (pH 7.5), 200 mM NaCl, 10% glycerol and eluted 
with 200 mM imidazole (pH 7.5), 200 mM NaCl, 10% glyc-
erol. In order to remove the attached C-terminal His10-tag 
and get rid of the imidazole the affinity-purified protein was 
dialyzed against 20 mM Tris/HCl pH 7.4, 150 mM NaCl and 
simultaneously cleaved by 3C protease. Finally, cleaved 
Rv1410 and LprG_trunc were again loaded on a Ni2+-NTA 
column to remove GFP/His10-tag and the His-tagged 3C 
protease and were separated by size exclusion chroma-
tography (SEC, Superdex 200 10/300 GL) in 20 mM Tris/
HCl pH 7.4, 150 mM NaCl, 0.03% β-DDM. Protein con-
centrations were determined by measuring A280 using 
NanoDrop 2000c.
Expression and purification of biotinylated Rv1410_AviC 
and MdfA_AviC containing a C-terminal Avi-tag
The purification of Avi-tagged versions of Rv1410 (Rv1410-
AviC) and MdfA (MdfA-AviC) was performed the same way 
as described above for Rv1410 with the exception that an 
additional biotinylation step was introduced between the 
Ni2+-NTA purification and the buffer exchange using a PD-10 
column. The eluted protein from the Ni2+-NTA column was 
concentrated to approximately 250 μl. A final concentration 
of 5 mM ATP, 10 mM MgOAc, a 2-fold excess of biotin over 
the Avi-tag concentration, 16 μg ml–1 BirA, 200 mM NaCl 
and 10% glycerol was added to the protein to reach a final 
volume of 2.5 ml. The biotinylation reaction was incubated 
for 16–18 h at 4°C. After this step the standard purification 
described above was performed.
Analytical size exclusion chromatography (SEC) to 
investigate Rv1410-LprG interaction
The main elution fractions of the monodisperse SEC peaks 
of the lipoprotein LprG_trunc and Rv1410 were first sepa-
rated individually by SEC (Superdex 200 10/300 GL) in 
20 mM Tris/HCl pH 7.4, 150 mM NaCl, 0.03% β-DDM. Then, 
the collected fractions of the main peak of each protein were 
pooled and the two proteins were mixed together. LprG_
trunc was added at a fivefold excess over the transporter 
Rv1410, incubated for 15 min on ice and analyzed by SEC.
Surface plasmon resonance
The affinity of the MFS transporter Rv1410 to the lipo-
protein LprG_trunc was assessed by SPR analysis 
on a ProteOn XPR36 protein interaction array system 
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(Bio-Rad). Biotinylated Rv1410-AviC (500 RU) and as a con-
trol biotinylated MdfA-AviC (500 RU) was immobilized on a 
NeutrAvidin coated NLC sensor chip in SPR buffer (20 mM 
Tris/HCl (pH 7.4), 150 mM NaCl, 0.05% Tween-20). LprG_
trunc was injected at six different concentrations (0, 2.4, 7.2, 
21.6, 64.8, 194.4 μM). SPR measurements were performed 
with 400 s contact time followed by 280 s dissociation time 
at a flow rate of 30 μl min–1. Given the fact that LprG_trunc 
interacted unspecifically with MdfA at the highest analyte 
concentrations, the data were not further quantified.
Expression tests of GFP-fused transporters in L. lactis 
and purification of Rv1410-GFP from L. lactis
L. lactis NZ9000 ΔlmrA ΔlmrCD cells (Venter et al., 2008) 
harboring plasmids encoding Rv1410-GFP, LmrP-GFP or 
MdfA-GFP were grown in GM17 Cm5 at 30°C. Expression 
was induced at an OD600 of 0.4-0.6 with nisin (culture 
supernatant of L. lactis NZ9700) for 2 h (1:1,000 (v/v)). 4 ml 
of cells were harvested in 2 ml tubes and resuspended in 
350 μl 20 mM Tris/HCl pH 8, 200 mM NaCl. A spatula tip 
of acid-washed glass beads ≤106 μm (Sigma) was added 
and the cells were subsequently lysed with a FastPrep-24 
Classic cell lysis machine (MP Biomedicals) for 3 cycles of 
60 s at a force of 6 m s–1. The lysate was spun 15 min at 
14,000 rpm at 4°C with a F-45-30-15 rotor (Eppendorf) to 
pellet glass beads and cell debris. The supernatant con-
taining membrane vesicles was pelleted by ultracentrifuga-
tion and the membrane pellet was dissolved in 10 μl of 5x 
SDS loading dye (120 mM Tris/HCl pH 6.8, 50% glycerol, 
100 mM DTT, 2% SDS (w/v), 0.1% bromophenol blue (w/v)), 
and separated by a 10% SDS-PAGE gel. The GFP-fusions 
were detected by in gel fluorescence with an ImageQuant 
LAS 4000 instrument (GE Healthcare).
For the purification of Rv1410, Rv1410-GFP was 
expressed in L. lactis NZ9000 ΔlmrA ΔlmrCD as described 
above using 4 liters of medium. The cell pellet was resus-
pended in PBS containing 15 mM K-EDTA and protease 
inhibitor. The cells were then disrupted using a Benchtop 
Microfluidizer M110PS (Microfluidics) 3 times at 30 kpsi. 
The cell lysate was centrifuged at 8,000 rpm at 4°C for 
10 min (Centrifuge 5804R, rotor: A-4-44 by Eppendorf) 
and the supernatant was incubated with 20 mM MgCl2 and 
DNase I (1:1,000 v/v) on ice for 30 min. Subsequently, ultra-
centrifugation was performed at 42,000 rpm and 4°C for 1 h 
using a Beckman Ti45 rotor. The pelleted membrane was 
resuspended in TBS containing 10% glycerol. Solubilization, 
protein purification via Ni2+-NTA, 3C protease cleavage and 
SEC was performed exactly as for Rv1410 purified from 
E. coli (see above).
Hoechst 33342, ethidium and BCECF-AM transport in 
L. lactis
L. lactis NZ9000 ΔlmrA ΔlmrCD cells (Venter et al., 2008) 
harboring plasmids encoding wild-type or mutant Rv1410, 
LmrP or MdfA were grown in GM17 Cm5 at 30°C. Expression 
was induced at an OD600 of 0.4-0.6 with nisin (culture 
supernatant of L. lactis NZ9700) for 1 h (1:1,000 (v/v)). 
Cells were washed and resuspended using fluorescence 
buffer (50 mM KPi pH 7.0, 5 mM MgSO4), adjusted to 
an OD600 of 0.5 and energized by adding 0.5% glucose. 
Accumulation of 5 μM ethidium, 0.5 μM Hoechst 33342 at 
25°C or 0.2 μM BCECF-AM at 30°C was followed for 600 s 
using a Fluorescence Spectrometer LS-55 (Perkin Elmer). 
Excitation and emission wavelengths and slit widths were 
set at 520, 10 and 595 nm, 15 nm for ethidium; 355, 5 and 
457 nm and 5 nm for Hoechst 33342; 502, 2.5 and 525 nm, 
4 nm for BCECF. Transport assays were conducted twice in 
two technical replicates. For clarity of discussion, one repre-
sentative dataset is shown.
Ethidium, BCECF-AM and calcein-AM transport in  
M. smegmatis
Wild-type M. smegmatis, M. smegmatis dKO 
(∆MSMEG_3069-70) and M. smegmatis ∆lfrA 
(∆MSMEG_6225) were inoculated into 25 ml of 7H9 
medium and incubated at 37°C while shaking at 160 rpm 
until the cultures reached mid-log growth phase (OD600 = 
0.5–1.0). The cultures were harvested by centrifugation, 
cell pellets were resuspended in 1 ml of 50 mM potas-
sium phosphate (KPi) buffer (pH = 7.0) and kept on ice. 
Prior to the experiment, cells were diluted using KPi buffer 
kept at 37°C to a final OD600 = 0.5. 2 ml of cell suspension 
was transferred to a Quartz SUPRASIL® cuvette (Hellma 
Analytics, 101-QS) (also warmed to 37°C). The cuvette was 
promptly placed in a LS 55 Fluorescence Spectrometer 
(PerkinElmer) that was connected to a MultiTemp III water 
bath (Pharmacia Biotech) to keep the temperature of the 
cuvette at 37°C and to a magnetic stirrer (Rank Brothers 
Ltd, model 300) to ensure the homogeneity of the diluted 
culture. Before each measurement, either 0.4% w/v glu-
cose or 500 μM carbonyl cyanide m-chlorophenyl hydra-
zone (CCCP) was added to the cells and incubated for 3 
min while stirring. The fluorescent dyes ethidium (5 μM), 
BCECF-AM (0.2 μM), and calcein-AM (0.2 μM) were added 
10 s after the start of fluorescence intensity measurements. 
Excitation and emission wavelengths and slit widths were 
set at 520, 10 and 595 nm, 15 nm for ethidium; at 502, 
2.5 and 525 nm, 4 nm for BCECF; at 495, 12 and 520 nm, 
12 nm for calcein. In the experiments shown in Fig. 4E, Glc 
was added, as described above, to energize the cells, but 
after 8 min 500 μM CCCP was added to the same sample 
to determine whether the presence of CCCP alters the flu-
orescence properties of BCECF and calcein. Average flu-
orescence intensities and 95% confidence intervals (using 
a Student’s t distribution) were calculated from the data of 
six biological replicates.
Minimal inhibitory concentration (MIC) measurements in 
M. abscessus and M. smegmatis
All antibiotics were purchased as powder from Sigma-
Aldrich (Buchs, Switzerland) and stock solutions were 
prepared. Novobiocin and vancomycin were dissolved in 
water, rifabutin and clofazimine in DMSO, tetracycline in 
ethanol and ofloxacin in a 0.1 M HCl solution. The MICs for 
M. abscessus and M. smegmatis were performed in 96-well 
plates as previously described (Dal Molin et al., 2018). The 
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MICs were determined on day 5 for M. smegmatis and 
M. abscessus.
Cellular growth assays in complemented M. smegmatis 
dKO cells
We developed a high-throughput growth assay in a 96-well 
format to assess the functionality of Rv1410 and LprG in 
M. smegmatis dKO cells. All tested strains (wild-type, dKO 
and dKO complemented with pFLAG vectors as described 
above) were grown to late stationary phase in 7H9 medium 
in the absence of antibiotics (this was possible because 
the pFLAG vector is stably integrated in the genome). 
From these pre-cultures, cells were diluted 1,000-fold into 
7H9 medium containing the following drug concentrations: 
for the experiments assessing the operons from different 
mycobacteria (Figs 1D and S1): vancomycin (0.3 μg ml–1), 
rifampicin (0.4 μg ml–1), or novobiocin (0.5 μg ml–1); for the 
experiments assessing the loop mutants (Fig. 2D–F): vanco-
mycin (0.0125 μg ml–1), rifampicin (0.075 μg ml–1), or novo-
biocin (0.05 μg ml–1). One milliliter of these cultures were 
transferred in 4–6 technical replicates into 96-well deep well 
plates and were incubated at 37°C, shaking at 300 rpm, for 
approximately 50 h. After removing 50 μl of each culture into 
96-well plates at indicated time points, OD600 was measured 
in a microtiter plate reader (Synergy H1 Hybrid Reader, 
BioTek). The presented growth curves are representatives 
of 3 biological replicates and error bars denote the standard 
deviation of technical replicates.
Transmission electron microscopy
Wild-type and dKO cells were grown to stationary phase 
and washed in buffer. Cells were fixed with 2.5% glutar-
aldehyde in 0.1 M sodium cacodylate buffer (pH 7.35) for 
at least 1 h and sequentially treated with 1% OsO4 for 1 
h at 0°C in 0.1 M sodium cacodylate buffer and 2% ura-
nyl acetate in H2O for 1 h at 4°C. Pellets of bacteria were 
embedded in 2% of Agar, subsequently dehydrated in an 
ethanol series and embedded in Epon/Araldite (Sigma-
Aldrich, Buchs, Switzerland). Ultrathin (50 nm) sections 
were contrasted with lead citrate (Reynolds) and imaged 
with a CM100 transmission electron microscope (Thermo 
Fisher Scientific, Eindhoven, The Netherlands) at an 
acceleration voltage of 80 kV using an Orius 1000 digital 
camera (Gatan, Munich, Germany).
Fluorescence microscopy
500 μl of stationary phase cultures of wild-type or dKO 
M. smegmatis carrying pIS220_Wag31-GFP (Santi et 
al., 2013) were inoculated into 10 ml of 7H9 medium with 
kanamycin (15 μg ml–1) (Sigma-Aldrich) and SynaptoRed 
C2 membrane dye (10 μg ml–1) (Sigma-Aldrich) and incu-
bated overnight at 37°C while shaking at 160 rpm until 
the cultures reached stationary phase (OD600 = 3–5). 
Experiments were conducted blinded until the last data 
analysis step. The stationary phase cultures were diluted 
1:10 in 7H9 medium and sonicated 3 times to reduce cell 
clumping (10 s 0 × 10% cycle at 80% power, Bandelin 
Sonopuls HD2200 sonicator). 200 μl cells were transferred 
on coverslips in 24 well plates and centrifuged for 10 min 
at 4,000 rpm and room temperature (Heraeus Multifuge 
4 KR centrifuge, Thermo Scientific) to attach the myco-
bacterial cells to the coverslips. Cells were fixed with 4% 
paraformaldehyde (PFA; Electron Microscopy Sciences) 
for 10 min at room temperature, washed twice with 2 ml 
of PBS buffer, mounted on glass-slides using ProLong 
Diamond Antifade Mountant (Invitrogen, Thermo Fisher 
Scientific) and incubated at 4°C overnight. The samples 
were analyzed in 3D on the next day with a Leica SP8 
inverse confocal laser scanning microscope (HC PL APO 
CS2 63x/1.4 OIL; Leica Microsystems) at excitation wave-
lengths of 488 and 561 nm to detect GFP and SynaptoRed 
respectively. The pictures were analyzed in a semi-auto-
mated workflow employing Fiji image processing package 
(Schindelin et al., 2012) and a custom script by Dr. Moritz 
Kirschmann (ZMB, UZH, Switzerland). In this image analy-
sis pipeline, consecutive poles or septa (labeled by flu-
orescence via Wag31-GFP fusion protein) of individual 
cell chains were marked manually. Each cell (chain) was 
saved as a region of interest (ROI) and the program calcu-
lated the number of cells per cell chain. Only cells that had 
been stained by SynaptoRed and harbored at least two 
Wag31-GFP foci on the cell poles were counted. Cells that 
were clustered or did not have defined boundaries on the 
3D pictures were excluded from the analysis. After hav-
ing counted the cells per cell chains from two biological 
replicates, the samples were de-blinded and data analysis 
was conducted using statistics software R (www.R-proj-
ect.org). The cell chains, whose length was longer than 
2 cells, were binned together and Pearson’s χ2 test was 
performed to evaluate the difference of distribution of cell 
chain lengths in the two strains.
Correlated optical fluorescence microscopy (OFM) and 
atomic force microscopy (AFM)
For AFM experiments, M. smegmatis wild-type and dKO 
strains were grown in Middlebrook 7H9 liquid medium (Difco) 
supplemented with 0.5% albumin, 0.2% glucose, 0.085% 
NaCl, 0.5% glycerol and 0.05% Tween-80. In order to con-
duct AFM measurements of wild-type and dKO strains in 
parallel under identical experimental settings, wild-type M. 
smegmatis was differentiated from dKO cells by expressing 
Wag31-GFP or Wag31-mCherry fusion protein from an ecto-
pic locus, integrated at attB, as described previously (Santi 
et al., 2013). Polydimethylsiloxane (PDMS)-coated covers-
lips were prepared by spin-coating a mixture of PDMS at a 
ratio of 15:1 (elastomer:curing agent) with hexane (Sigma 
296090) at a ratio of 1:10 (PDMS:hexane) (Thangawng et 
al., 2007; Koschwanez et al., 2009). An aliquot of bacteria 
was grown to mid-exponential phase and 2–5 ml of cul-
ture was filtered (5 μm pore size PVDF filter – Millipore) to 
select for individual cells and concentrated to 50 μl. Wild-
type cells expressing Wag31-GFP or Wag31-mCherry were 
mixed with the non-fluorescent dKO mutant, deposited 
onto the PDMS-coated coverslip and incubated for ~20 min 
to increase surface interactions between the hydrophobic 
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bacterial surface and the coverslip. Correlated optical flu-
orescence and AFM images were acquired as described in 
Eskandarian et al. (2017). Optical fluorescence images were 
acquired with an electron-multiplying charge-coupled device 
(EMCCD) iXon Ultra 897 camera (Andor), mounted on an 
IX81 inverted optical microscope (Olympus), and equipped 
with an UPLFLN100XO2PH × 100 oil immersion objective 
(Olympus). Transmitted light illumination was provided by a 
12V/100W AHS-LAMP halogen lamp. A U-MGFPHQ fluo-
rescence filter cube for GFP with HQ-Ion-coated filters was 
used together with a bandpass barrier filter, exciter filter 
BP460-480HQ, a dichroic beam splitter DM485, and barrier 
filter BA495-540HQ to detect green and red fluorescence 
originating from Wag31-GFP and Wag31-mCherry fusion 
protein respectively. The AFM was mounted on top of the 
inverted microscope and 7H9 medium (~3 ml) was supplied 
to the sample to immerse the bacterial sample and the AFM 
cantilever in fluid. Images were acquired with a Dimension 
Icon scan head (Bruker) using ScanAsyst fluid cantilevers 
(Bruker) with a nominal spring constant of 0.7 N m–1 in Peak 
Force QNM mode at a force setpoint ~1nN and typical scan 
rates of 0.5 Hz. Indentation on the cell surface was esti-
mated to be ~10 nm with a range of ~5 nm in the Z-axis. 
Height, peak force error, DMT modulus, and log DMT mod-
ulus were recorded for all scanned images in the trace and 
retrace directions. Images were processed using Gwyddion 
(Department of Nanometrology, Czech Metrology Institute 
- http://gwyddion.net). ImageJ was used for extracting bac-
terial cell profiles in a tabular form. The data were analyzed 
using a two-sided Wilcoxon rank sum test with continuity 
correction and confidence level of 95% using statistics soft-
ware R (www.R-project.org).
Data availability
AFM raw data are available at: https://figshare.com/
s/088396e3e85b87530455, DOI:10.6084/m9.figshare. 
7364810.
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SR carried out dye transport experiments in M. smeg-
matis and L. lactis. HAE performed AFM experiments. 
SR performed and analyzed fluorescence microscopy 
experiments. MH prepared the samples for TEM. FMA 
generated M. smegmatis ΔlfrA. LMH and AK cloned 
transporters into L. lactis, performed transport exper-
iments in L. lactis, determined expression levels of 
GFP-fusion proteins and purified Rv1410 from L. lactis. 
MH, SR, HAE, MDM, LMH, AK, PS and MAS analyzed 
and interpreted the data. MH, LMH, GEF, PS and MAS 
supervised students and postdocs. MH, SR, HAE and 
MAS wrote the paper. MDM and PS edited the paper.
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